A comparison of oncogene-induced senescence and replicative senescence: Implications for tumor suppression and aging

Age

Volumn 36, Issue 3, 2014, Pages 1049-1065

  Nelson, David M ^a,b   McBryan, Tony ^a,b   Jeyapalan, Jessie C ^c   Sedivy, John M ^c   Adams, Peter D ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c BROWN UNIVERSITY   (United States)

Author keywords

Aging; Cancer; Gene expression; Oncogene induced senescence; Replicative senescence

Indexed keywords

AGING; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; ONCOGENE INDUCED SENESCENCE; REPLICATIVE SENESCENCE; SENESCENCE; TELOMERE SHORTENING; CELL AGING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; METABOLISM; NEOPLASM; ONCOGENE; TELOMERE; TUMOR CELL CULTURE;

RNA;

AGING; CELL AGING; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; NEOPLASMS; ONCOGENES; RNA, NEOPLASM; TELOMERE; TELOMERE SHORTENING; TUMOR CELLS, CULTURED;

EID: 84905408918     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-014-9637-0     Document Type: Article

References (47)

1. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N, Takatsu Y, Melamed J, AddadiFagagna F, Bernard D, Hernando E, Gil J (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133(6):1006-1018. doi:10.1016/j.cell.2008. 03.038 (Pubitemid 351795610)
2. Adams PD (2009) Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 36(1):2-14. doi:10.1016/j.molcel. 2009.09.021
3. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (7372):232-236. doi:10.1038/nature10600
4. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444(7119):633-637 (Pubitemid 44864442)
5. Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6(8):611-622. doi:10.1038/nrg1656 (Pubitemid 41044298)
6. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279(5349):349-352 (Pubitemid 28063364)
7. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436(7051):660-665 (Pubitemid 41117262)
8. Burton DG, Giles PJ, Sheerin AN, Smith SK, Lawton JJ, Ostler EL, Rhys-Williams W, Kipling D, Faragher RG (2009) Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification. Exp Gerontol 44(10):659-665. doi:10.1016/j.exger.2009.07.004
9. Chen WV, Maniatis T (2013) Clustered protocadherins. Development 140(16):3297-3302. doi:10.1242/dev.090621
10. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436(7051):725-730 (Pubitemid 41117277)
11. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M (2005) Tumour biology: senescence in premalignant tumours. Nature 436(7051):642 (Pubitemid 41117258)
12. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6 (12):2853-2868. doi:10.1371/journal.pbio.0060301
13. Coppe JP, Desprez PY, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99-118. doi:10.1146/annurev-pathol-121808-102144
14. Cosme-Blanco W, Shen MF, Lazar AJ, Pathak S, Lozano G, Multani AS, Chang S (2007) Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep 8(5):497-503 (Pubitemid 46696521)
15. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein PE, MacCollin M, Cichowski K (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10(6):459-472 (Pubitemid 44872980)
16. d'Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8 (7):512-522
17. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92(20):9363-9367
18. Feldser DM, Greider CW (2007) Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11(5):461-469 (Pubitemid 46670077)
19. Freund A, Laberge RM, Demaria M, Campisi J (2012) Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell. doi:10.1091/mbc.E11-10-0884
20. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G (1996) Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16(3):859-867
21. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621
22. Jeyapalan JC, Sedivy JM (2013) How tomeasure RNA expression in rare senescent cells expressing any specific protein such as p16Ink4a. Aging (Albany NY) 5(2):120-129
23. Jun JI, Lau LF (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12(7):676-685. doi:10.1038/ncb2070
24. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, Iken M, Vucur M, Weiss S, Heikenwalder M, Khan S, Gil J, Bruder D, Manns M, Schirmacher P, Tacke F, Ott M, Luedde T, Longerich T, Kubicka S, Zender L (2011) Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479 (7374):547-551. doi:10.1038/nature10599
25. Kipling D, Jones DL, Smith SK, Giles PJ, Jennert-Burston K, Ibrahim B, Sheerin AN, Evans AJ, Rhys-Willams W, Faragher RG (2009) A transcriptomic analysis of the EK1.Br strain of human fibroblastoid keratocytes: the effects of growth, quiescence and senescence. Exp Eye Res 88(2):277-285. doi:10.1016/j.exer.2008.11.030
26. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134 (4):657-667. doi:10.1016/j.cell.2008.06.049
27. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98(21):12072-12077. doi:10.1073/pnas.211053698 (Pubitemid 32959828)
28. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133 (6):1019-1031. doi:10.1016/j.cell.2008.03.039 (Pubitemid 351787746)
29. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS (2010) The essence of senescence. Genes Dev 24 (22):2463-2479. doi:10.1101/gad.1971610
30. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436(7051):720-724 (Pubitemid 41117276)
31. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267-273. doi:10.1038/ng1180 (Pubitemid 36792858)
32. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113(6):703-716 (Pubitemid 36724935)
33. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211(1):90-98. doi:10.1006/excr.1994.1063 (Pubitemid 24167339)
34. Osorio FG, Lopez-Otin C, Freije JM (2012) NF-kB in premature aging. Aging (Albany NY) 4(11):726-727
35. Riabowol KT (1992) Transcription factor activity during cellular aging of human diploid fibroblasts. Biochem Cell Biol 70(10-11):1064-1072
36. Salama R, Sadaie M, Hoare M, Narita M (2014) Cellular senescence and its effector programs. Genes Dev 28(2):99-114. doi:10.1101/gad.235184.113
37. Saretzki G, von Zglinicki T (2002) Replicative aging, telomeres, and oxidative stress. Ann N YAcad Sci 959:24-29 (Pubitemid 34457548)
38. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5):593-602 (Pubitemid 27152402)
39. Sherr CJ, DePinho RA (2000) Cellular senescence: mitotic clock or culture shock? Cell 102(4):407-410
40. Shimi T, Butin-Israeli V, Adam SA, Hamanaka RB, Goldman AE, Lucas CA, Shumaker DK, Kosak ST, Chandel NS, Goldman RD (2011) The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev 25(24):2579-2593. doi:10.1101/gad.179515.111
41. Singh T, Newman AB (2011) Inflammatory markers in population studies of aging. Ageing Res Rev 10(3):319-329. doi:10.1016/j.arr.2010.11.002
42. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545-15550. doi:10.1073/pnas.0506580102 (Pubitemid 41528093)
43. Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, Boccardi V, Fumagalli M, Di Micco R, Mirani N, Gurung RL, Hande MP, d'Adda di Fagagna F, Herbig U (2012) Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J 31 (13):2839-2851. doi:10.1038/emboj. 2012.132
44. Whitfield ML, George LK, Grant GD, Perou CM (2006) Common markers of proliferation. Nat Rev Cancer 6 (2):99-106. doi:10.1038/nrc1802 (Pubitemid 43361542)
45. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445(7128):656-660 (Pubitemid 46232886)
46. Ye X, Zerlanko B, Kennedy A, Banumathy G, Zhang R, Adams PD (2007) Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol Cell 27(2):183-196 (Pubitemid 47058300)
47. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, Tavare S, Arakawa S, Shimizu S, Watt FM (2009) Autophagy mediates the mitotic senescence transition. Genes Dev 23(7):798-803. doi:10.1101/gad.519709